. Discovery of a Highly Selective and Potent TRPC3 Inhibitor with High Metabolic Stability and Low Toxicity. ACS Med Chem Lett. 2021 Apr 8;12(4):572-578. Epub 2021 Mar 5 PubMed.


Please login to recommend the paper.


No Available Comments

Make a Comment

To make a comment you must login or register.